https://www.selleckchem.com/pr....oducts/BafilomycinA1
Medication is often changed after hospital discharge in people with Parkinson's disease (PD). This observational study aimed to describe changes in PD medication after discharge and explore their association with self-reported adherence and clinical parameters. During hospitalisation sociodemographic characteristics, the Movement Disorder Society-sponsored revision of the Unified PD Rating Scale for motor function (MDS-UPDRS III), Hoehn and Yahr (HY) stage, levodopa equivalent daily dose (LEDD), Beck Depression Inventory II (
Curtir
Comentario
Compartilhar
